Fu Jun, Dai Shixu, Lu Yuanyuan, Wu Rui, Wang Zhaoxia, Yuan Yun, Lv He
Department of Neurology, First Hospital, Peking University, Beijing 100034, China.
Department of Neurology, First Hospital, Peking University, Beijing 100034, China.
Neuromuscul Disord. 2017 Aug;27(8):760-765. doi: 10.1016/j.nmd.2017.04.001. Epub 2017 Apr 20.
Mutations in the ganglioside-induced differentiation-associated protein 1 gene (GDAP1) cause rare subtypes of Charcot-Marie-Tooth disease (CMT2K and CMT4A). CMT2K is an axonal neuropathy while CMT4A is a demyelinating type. In a series of 169 Chinese CMT patients (79 CMT1, 52 CMT2 and 38 unclassified), four unrelated patients (2.37%) were identified with GDAP1 mutations, including two with autosomal recessive CMT2K (AR-CMT2K) and two dominant CMT2K (AD-CMT2K). All patients had disease onset before 5 years of age, and presented with muscle weakness, atrophy, and mild sensory disturbance in distal limbs. Motor nerve conduction velocities of the median nerve were within normal ranges, and compound muscle action potential ranged from 1.5 to 3.8 mV. Sural nerve biopsy revealed loss of large myelinated fibers with regeneration clusters and a few onion bulbs. Electron microscopy showed mitochondrial aggregation in both axons and Schwann cells, and neurofilament accumulation in giant unmyelinated fibers. The p.H256R mutation was found in all patients with GDAP1 compound heterozygous mutations, suggesting that it might be a common mutation in Chinese patients. This study observed no difference in the disease onset, phenotype severity, electrophysiological findings, or pathological changes between AR-CMT2K and AD-CMT2K patients.
神经节苷脂诱导分化相关蛋白1基因(GDAP1)突变可导致罕见亚型的夏科-马里-图斯病(CMT2K和CMT4A)。CMT2K是一种轴索性神经病,而CMT4A是脱髓鞘型。在一组169例中国CMT患者(79例CMT1、52例CMT2和38例未分类)中,鉴定出4例无关患者(2.37%)存在GDAP1突变,包括2例常染色体隐性CMT2K(AR-CMT2K)和2例显性CMT2K(AD-CMT2K)。所有患者在5岁前发病,表现为肌肉无力、萎缩以及远端肢体轻度感觉障碍。正中神经运动神经传导速度在正常范围内,复合肌肉动作电位范围为1.5至3.8mV。腓肠神经活检显示有大的有髓纤维缺失,伴有再生簇和少量洋葱球样结构。电子显微镜检查显示轴突和施万细胞中均有线粒体聚集,以及巨大无髓纤维中有神经丝积聚。在所有携带GDAP1复合杂合突变的患者中均发现了p.H256R突变,提示其可能是中国患者中的常见突变。本研究观察到AR-CMT2K和AD-CMT2K患者在发病年龄、表型严重程度、电生理检查结果或病理变化方面无差异。